Mathai Mammen
2009
In 2009, Mathai Mammen earned a total compensation of $1.2M as Senior Vice President, Research Early Clinical Development at Innoviva, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $321,138 |
|---|---|
| Salary | $327,500 |
| Stock Awards | $542,050 |
| Other | $148 |
| Total | $1,190,836 |
Mammen received $542.1K in stock awards, accounting for 46% of the total pay in 2009.
Mammen also received $321.1K in non-equity incentive plan, $327.5K in salary and $148 in other compensation.
Rankings
In 2009, Mathai Mammen's compensation ranked 3,867th out of 9,885 executives tracked by ExecPay. In other words, Mammen earned more than 60.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,867 out of 9,885 | 61st |
Division Manufacturing | 1,369 out of 3,690 | 63rd |
Major group Chemicals And Allied Products | 259 out of 866 | 70th |
Industry group Drugs | 150 out of 638 | 77th |
Industry Pharmaceutical Preparations | 118 out of 446 | 74th |
Source: SEC filing on April 16, 2012.
Mammen's colleagues
We found four more compensation records of executives who worked with Mathai Mammen at Innoviva in 2009.